BIOINVENT INTERNATIONAL AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
Översikt
- Okänt
- Anställda
- Okänt
- Omsättning
- 1997
- Grundat
Nyckelbeslutsfattare
Cecilia Hofvander
VP Investor Relations
Nanna Lüneborg
Member of the Board
Björn Frendéus
CSO
Martin Welschof
CEO
+19 fler kontakter i Funnelfeedr
Beskrivning
BioInvent International AB is a clinical-stage company focused on discovering and developing novel antibody therapeutics for cancer treatment. The core of their work lies in immuno-oncology, leveraging deep expertise in immunology, cancer biology, and antibody biology. They utilize their proprietary...